BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10589951)

  • 1. The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation.
    Fernandez LA; Lehmann R; Luzi L; Battezzati A; Angelico MC; Ricordi C; Tzakis A; Alejandro R
    Transplantation; 1999 Nov; 68(10):1532-41. PubMed ID: 10589951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study.
    Ericzon B; Groth C; Bismuth H; Calne R; McMaster P; Neuhaus P; Otto G; Pichlmayr R; Williams R
    Transpl Int; 1994; 7 Suppl 1():S11-4. PubMed ID: 11271178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
    Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A
    Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for impaired glucose effectiveness in cirrhotic patients after liver transplantation.
    Konrad T; Steinmüller T; Vicini P; Toffolo G; Grewerus D; Schüller A; Bechstein WO; Usadel KH; Cobelli C; Mahon A; Wittmann W; Klar E; Golling M; Neuhaus P
    Metabolism; 2000 Mar; 49(3):367-72. PubMed ID: 10726916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients.
    Krentz AJ; Dousset B; Mayer D; McMaster P; Buckels J; Cramb R; Smith JM; Nattrass M
    Diabetes; 1993 Dec; 42(12):1753-9. PubMed ID: 7694879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of glucose tolerance in patients after liver transplantation: impact of cyclosporin versus tacrolimus therapy.
    Konrad T; Steinmüller T; Vicini P; Toffolo G; Grewerus D; Schüller A; Bechstein WO; Usadel KH; Cobelli C; Neuhaus P
    Transplantation; 2000 May; 69(10):2072-8. PubMed ID: 10852599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
    Lohmann T; List C; Lamesch P; Kohlhaw K; Wenzke M; Schwarz C; Richter O; Hauss J; Seissler J
    Exp Clin Endocrinol Diabetes; 2000; 108(5):347-52. PubMed ID: 10989953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.
    Ramos-Cebrián M; Torregrosa JV; Gutiérrez-Dalmau A; Oppenheimer F; Campistol JM
    Transplant Proc; 2007 Sep; 39(7):2251-3. PubMed ID: 17889154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial.
    Steinmüller TM; Gräf KJ; Schleicher J; Leder K; Bechstein WO; Mueller AR; Dette K; Schulz E; Neuhaus P
    Transplantation; 1994 Sep; 58(6):669-74. PubMed ID: 7524203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling technique.
    Steinmueller T; Konrad T; Vicini P; Toffolo G; Jonas S; Tullius S; Bechstein WO; Cobelli C; Usadel KH; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1452-3. PubMed ID: 9636589
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation.
    Bouchta NB; Ghisdal L; Abramowicz D; Broeders N; Surquin M; Hoang AD; Wissing KM
    Transplant Proc; 2005 May; 37(4):1857-60. PubMed ID: 15919485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients.
    Platz KP; Mueller AR; Blumhardt G; Bachmann S; Bechstein WO; Kahl A; Neuhaus P
    Transpl Int; 1994; 7 Suppl 1():S52-7. PubMed ID: 11271297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients.
    Sakr M; Hassanein T; Gavaler J; Abu-Elmagd K; Fung J; Gordon R; Starzl T; Van Thiel D
    Transplantation; 1992 Apr; 53(4):786-91. PubMed ID: 1373535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients.
    Filler G; Neuschulz I; Vollmer I; Amendt P; Hocher B
    Nephrol Dial Transplant; 2000 Jun; 15(6):867-71. PubMed ID: 10831643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.
    Drachenberg CB; Klassen DK; Weir MR; Wiland A; Fink JC; Bartlett ST; Cangro CB; Blahut S; Papadimitriou JC
    Transplantation; 1999 Aug; 68(3):396-402. PubMed ID: 10459544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cyclosporine vs FK 506 on glucose metabolism.
    Steinmueller T; Konrad T; Jonas S; Tullius S; Bechstein WO; Mueller A; Platz KP; Neumann U; Vicini P; Toffolo G; Cobelli C; Usadel KH; Neuhaus P
    Transplant Proc; 1999; 31(1-2):1129-30. PubMed ID: 10083504
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.
    Hohage H; Arlt M; Brückner D; Dietl KH; Zidek W; Spieker C
    Clin Transplant; 1997 Jun; 11(3):225-30. PubMed ID: 9193847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A.
    Kanzler S; Lohse AW; Schirmacher P; Hermann E; Otto G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1996 Feb; 34(2):128-31. PubMed ID: 8659188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose and leucine metabolism in lung tranplanted patients on low dose of steroids for immunosuppressive therapy.
    Benedini S; Ruffini E; Terruzzi I; Mancuso M; Luzi L
    Transplant Proc; 2008 Jun; 40(5):1566-71. PubMed ID: 18589153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.
    Taler SJ; Textor SC; Canzanello VJ; Schwartz L; Porayko M; Wiesner RH; Krom RA
    Transplantation; 1996 Dec; 62(11):1588-92. PubMed ID: 8970613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.